Oyster Point Pharma Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Oyster Point Pharma Inc
Access all reports
Oyster Point Pharma, Inc. is a biopharmaceutical company focused on developing therapies to address ophthalmic diseases. The company's primary area of focus is the treatment of dry eye disease and other ocular surface conditions. Oyster Point leverages its expertise in neuroscience and ophthalmology to develop innovative therapeutic solutions that aim to improve eye health and patient quality of life. The company serves the healthcare sector, specifically targeting the ophthalmology field with products designed to meet unmet medical needs in eye care. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
OYST
Country
🇺🇸 United States